Investors Lend Satori $15 Million, Hoping It Converts To An Alzheimer's Treatment
This article was originally published in The Pink Sheet Daily
Executive Summary
The venture-backed Cambridge, Mass. firm says it can get its small-molecule gamma-secretase modulator into the clinic next year.